Marimed Inc. (MRMD.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,882 | 2,789 | 3,083 | 2,756 | 3,044 |
| Accounts receivable | -1,402 | -328 | 1,604 | -303 | -1,216 |
| Accounts payable and accrued liabilities | 3,531 | 23 | -2,799 | 86 | -32 |
| Other Working Capital | 4,018 | 2,627 | -2,602 | 1,757 | 4,571 |
| Other Operating Activity | -5,600 | -2,435 | 1,011 | -3,003 | -6,780 |
| Operating Cash Flow | $3,429 | $2,676 | $297 | $1,293 | $-413 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33 | -559 | -309 | -266 | -1,058 |
| Net Acquisitions | 0 | 0 | 0 | 181 | -100 |
| Purchase Sale Intangibles | -164 | 0 | -245 | -56 | -49 |
| Other Investing Activity | 0 | 45 | 0 | 26 | 7 |
| Investing Cash Flow | $-197 | $-514 | $-554 | $-115 | $-1,200 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 2,000 | 0 | 0 |
| Debt Repayment | -922 | -1,670 | -2,774 | -1,201 | -874 |
| Dividend Paid | -22 | -34 | -23 | -58 | -19 |
| Other Financing Activity | 0 | 0 | -9 | 0 | 0 |
| Financing Cash Flow | $-944 | $-1,704 | $-806 | $-1,259 | $-893 |
| Beginning Cash Position | 6,596 | 6,138 | 7,201 | 7,282 | 9,788 |
| End Cash Position | 8,884 | 6,596 | 6,138 | 7,201 | 7,282 |
| Net Cash Flow | $2,288 | $458 | $-1,063 | $-81 | $-2,506 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,429 | 2,676 | 297 | 1,293 | -413 |
| Capital Expenditure | -197 | -559 | -554 | -322 | -1,107 |
| Free Cash Flow | 3,232 | 2,117 | -257 | 971 | -1,520 |